• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Carlyle Secured Lending Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    5/6/25 4:21:50 PM ET
    $CGBD
    Finance: Consumer Services
    Finance
    Get the next $CGBD alert in real time by email
    csl-20250506
    false000154420600015442062025-05-062025-05-060001544206us-gaap:CommonStockMember2025-05-062025-05-060001544206csl:A2028SeniorUnsecuredNotesMember2025-05-062025-05-06

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): May 6, 2025
    Carlyle Secured Lending, Inc.
    (Exact name of registrant as specified in its charter)
    Maryland 814-00995 80-0789789
    (State or Other Jurisdiction
    of Incorporation)
     (Commission
    File Number)
     (IRS Employer
    Identification No.)
    One Vanderbilt Avenue, Suite 3400
    New YorkNew York 10017
    (Address of Principal Executive Offices) (Zip Code)
    (212) 813-4900
    (Registrant’s Telephone Number, Including Area Code)
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common StockCGBDThe Nasdaq Global Select Market
    8.20% Notes due 2028CGBDLThe Nasdaq Global Select Market
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
        Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 2.02 – Results of Operations and Financial Condition.
    On May 6, 2025, Carlyle Secured Lending, Inc. (the “Company”) issued a press release announcing its first quarter ended March 31, 2025 financial results and a detailed earnings presentation. Copies of the press release and the earnings presentation are attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively.
    The information disclosed under this Item 2.02, including Exhibits 99.1 and 99.2 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933 (the “Securities Act”) or the Exchange Act, except as expressly set forth by specific reference in such filing.
    Item 7.01 – Regulation FD Disclosure.
    On May 6, 2025, the Company issued a press release, included herewith as Exhibit 99.1, announcing its first quarter ended 2025 financial results and the declaration of a second quarter 2025 base dividend of $0.40 per share payable on July 17, 2025 to stockholders of record as of June 30, 2025.
    The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, and shall not be deemed incorporated by reference into any filing made under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.
    Item 9.01 – Financial Statements and Exhibits.
    Exhibits 99.1 and 99.2 shall be deemed furnished herewith.

    (d)Exhibits:
    Exhibit Number  Description
    99.1  
    Earnings press release of Carlyle Secured Lending, Inc., dated May 6, 2025.
    99.2
    Earnings presentation of Carlyle Secured Lending, Inc., dated May 6, 2025.




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
      CARLYLE SECURED LENDING, INC.
      (Registrant)
    Dated: May 6, 2025 By: /s/ Thomas M. Hennigan
      Name: Thomas M. Hennigan
      Title: Chief Financial Officer

    Get the next $CGBD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CGBD

    DatePrice TargetRatingAnalyst
    2/10/2025$17.00Buy → Underperform
    BofA Securities
    7/29/2024$17.00Neutral → Underweight
    JP Morgan
    7/28/2023$16.00Neutral
    B. Riley Securities
    9/6/2022$14.50Overweight → Neutral
    JP Morgan
    12/16/2021$15.00Perform
    Oppenheimer
    More analyst ratings